Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence

By Gesemann M.   Scheiermann N.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 443-447

Elsevier

Access to resources Recommend Favorite

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

By Van Herck K.   Van Damme P.   Thoelen S.   Meheus A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1933-1935

Elsevier

Access to resources Recommend Favorite

Subtype specificity of anti-HBs antibodies produced by human B-cell lines isolated from normal individuals vaccinated with recombinant hepatitis B vaccine

By Shokrgozar M.A.   Shokri F.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2215-2220

Elsevier

Access to resources Recommend Favorite

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines

By Heijtink R.A.   van Bergen P.   Paulij W.P.   de Man R.A.   Osterhaus A.D.M.E.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1531-1538

Elsevier

Access to resources Recommend Favorite

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

By Rey D.   Krantz V.   Partisani M.   Schmitt M.-P.   Meyer P.   Libbrecht E.   Wendling M.-J.   Vetter D.   Nicolle M.   Kempf-Durepaire G.   Lang J.-M.  

Vaccine, Vol. 18, Iss. 13, 2000-01 ,pp. : 1161-1165

Elsevier

Access to resources Recommend Favorite